OREX Description — Orexigen Therapeutics Inc
Orexigen Therapeutics is a biopharmaceutical company focused on the treatment of obesity. Co.'s sole product, Contrave® (naltrexone HCl/bupropion HCl prolonged release), is an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index of 30 kg/m2 or greater (obese), or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition. Contrave is a combination of generic drug components, each of which has already received regulatory approval for other indications and has been commercialized in the U.S. and in several of the member countries of the European Union.